BIMAGRUMAB NA REDUÇÃO DE GORDURA CORPORAL E MANUTENÇÃO/INCREMENTO DE MASSA MAGRA: REVISÃO SISTEMÁTICA COM COMPARADOR SEMAGLUTIDA
Eros Andria Maliska Lovatel, Rafael Rauber, MARIA LUIZA PARRA REZENDE, Jaqueline de Paula e Silva, Victor Hugo Rodrigues Cruz · 2026
Read BIMAGRUMAB NA REDUÇÃO DE GORDURA CORPORAL E MANUTENÇÃO/INCREMENTO DE MASSA MAGRA: REVISÃO SISTEMÁTICA COM COMPARADOR SEMAGLUTIDA by Eros Andria Maliska Lovatel, Rafael Rauber, MARIA LUIZA PARRA REZENDE, Jaqueline de Paula e Silva, Victor Hugo Rodrigues Cruz (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/openalex-w7214808228.txt.
Description
Eros Andria Maliska Lovatel led a 2026 systematic review comparing two weight-loss drugs on body composition in adults with overweight or obesity. Semaglutide is highly effective for weight loss, but a large share of the weight lost can be lean mass, which harms metabolism and function. Bimagrumab, an antibody drug that blocks a growth-limiting receptor, is tested here as the alternative.
In the reviewed evidence, bimagrumab cut body fat by more than a fifth while meaningfully increasing lean mass. It aided mobility and quality of life, especially for people with type 2 diabetes at risk of muscle loss. Both drugs were moderately tolerated. The authors still advise pairing drug treatment with resistance exercise to protect muscle, above all alongside semaglutide. They present bimagrumab as the more promising option for preserving and building lean mass.
Catalog record
| CREATOR | Eros Andria Maliska Lovatel, Rafael Rauber, MARIA LUIZA PARRA REZENDE, Jaqueline de Paula e Silva, Victor Hugo Rodrigues Cruz |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | OpenAlex / Revista Ibero-Americana de Humanidades, Ciências e Educação |